Cyclin D1 (CCND1) antibody

Antigen: Cyclin D1 (CCND1)

Synonyms: BCL1, PRAD1, U21B31, D11S287E, cD1, Cyl-1, bcl-1, AI327039, DIP1, GCIP, Maid, SECC-8, SSEC-8, AU022347, cb161, cycd1, fb52e01, fc83a12, id:ibd1198, wu:fb52e01, wu:fc83a12, MGC109078, ccnd1b, MGC52909, MGC132138, ccnd1, MGC53090, bcl1, prad1, u21b31, MGC69515, d11s287e, CCND1, ccndbp1, MGC137744, ZHM, CCNDBP1, MGC133757, DKFZp468E2216, DKFZp469C1216, DKFZp469H0317

Clonality: Monoclonal

Host: Rabbit

Reactivity: Human, Rat (Rattus)

Conjugate: Un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP)

Certificates: ISO 9001:2008

Catalog no.: ABIN649584

Additional Information

Alternative name: Cyclin D1

Gene ID: 4288

UniProt: P24385

Description: Other names: CCND1, BCL1, PRAD1, G1/S-specific cyclin-D1, PRAD1 oncogene,BCL-1 oncogene

Characteristics: Rabbit Monoclonal Antibody

Specificity: A synthetic peptide from C-terminus of human cyclin D1.

Molecular Weight: 36 kDA

Comments:

Background: Cyclin D1 belongs to the Cyclin D family. Cyclin D1 is required for the cell cycle G1/S transition (1). Cyclin D1 forms a serine/threonine kinase holoenzyme complex with and functions as a regulatory subunit of CDK4 or CDK6. Cyclin D1 also phosphorylates and inactivates the retinoblastoma protein and promotes progression through the G1/S phase (2-3). Amplification or overexpression of cyclin D1 plays a pivotal role in the development of various human cancers including parathyroid adenoma, breast cancer, colon cancer, lymphoma, melanoma, and prostate cancer (4). Over-expression of cyclin D1 is known to correlate with the early onset of cancer and risk of tumor progression and metastasis (5). Cyclin D1 also associates with, and regulates the activity of transcription factors, coactivators and corepressors that govern histone acetylation and chromatin remodeling proteins (6-7).

Synonyms: BCL1, PRAD1, U21B31, D11S287E, cD1, Cyl-1, bcl-1, AI327039, DIP1, GCIP, Maid, SECC-8, SSEC-8, AU022347, cb161, cycd1, fb52e01, fc83a12, id:ibd1198, wu:fb52e01, wu:fc83a12, MGC109078, ccnd1b, MGC52909, MGC132138, ccnd1, MGC53090, bcl1, prad1, u21b31, MGC69515, d11s287e, CCND1, ccndbp1, MGC137744, ZHM, CCNDBP1, MGC133757, DKFZp468E2216, DKFZp469C1216, DKFZp469H0317

Application Details

Application Notes: The suggested dilution is: WB: ~~ 1:5000 IP: ~~ 1:20 IHC: ~~ 1:100

Buffer: 50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA.

Storage: Cyclin D1 Antibody can be stored at -20°C for up to 12 months from time of receipt.

Research Area: Ubiquitin-related antibodies, Phospho-specific antibodies, Protein Modifications, Cancer, Cell Cycle, Signaling, Chromatin, Cell Structure

Restrictions: For Research Use only

Publications

Product: Inaba, Matsushime, Valentine et al.: "Genomic organization, chromosomal localization, and independent expression of human cyclin D genes." in: Genomics, Vol. 13, Issue 3, pp. 565-74, 1992 (PubMed).

Motokura, Arnold: "PRAD1/cyclin D1 proto-oncogene: genomic organization, 5' DNA sequence, and sequence of a tumor-specific rearrangement breakpoint." in: Genes, chromosomes & cancer, Vol. 7, Issue 2, pp. 89-95, 1993 (PubMed).

Baldin, Lukas, Marcote et al.: "Cyclin D1 is a nuclear protein required for cell cycle progression in G1." in: Genes & development, Vol. 7, Issue 5, pp. 812-21, 1993 (PubMed).

Neumeister, Pixley, Xiong et al.: "Cyclin D1 governs adhesion and motility of macrophages." in: Molecular biology of the cell, Vol. 14, Issue 5, pp. 2005-15, 2003 (PubMed).

Wang, Li, Fu et al.: "Signal transduction mediated by cyclin D1: from mitogens to cell proliferation: a molecular target with therapeutic potential." in: Cancer treatment and research, Vol. 119, pp. 217-37, 2004 (PubMed).